TON Strategy Co. Q4 FY2024 earnings call

• Historical context: Originally an R&D-driven SaaS business with challenges like high sales rep attrition, outdated policies, and competitive pricing led to selling the direct sales SaaS unit and focusing on MARKET.live. - Capital markets strategy: Used Reg A to restructure financing, paid off debt, redeemed preferred shares, resulting in a debt-free balance sheet with over $16M in shareholder equity and a tight share float. - Diversification: Entered telehealth with VANITY Prescribed, GoodGirlRX, and GO FUND YOURSELF; GO FUND YOURSELF saw revenue growth. - AI strategy: Acquired LyveCom's technology for MARKET.live platform, expecting operational cost reduction and accretive value.

MARKET.live: In 2024, Q1 revenue was $7,000, Q2 was $37,000, Q3 was $103,000, and Q4 was $490,000. Combined 2024 revenue was $895,000, a 1,321% increase over 2023. Q4 2024 revenue was $723,000, up $694,000 from the same period last year and up $595,000 from Q3 2024 (465% quarter-over-quarter). GO FUND YOURSELF: Generated $25,000 in revenue in Q3 2024 and $233,000 in Q4 2024. VANITY Prescribed: Had modest revenue growth during Q3 and Q4 2024 while developing and preparing for a broad-based launch and marketing campaign.

• Expectation that Q1 2025 will surpass Q4 2024.

• Predatory financing terms in capital markets causing share price erosion, reverse splits, and de-listings. - Dependence on market and regulatory changes affecting revenue streams.